INNOVUS PHARMACEUTICALS, INC.
Profile
Company Names
INNOVUS PHARMACEUTICALS, INC.
Addresses
8845 REHCO ROAD, SAN DIEGO, CA 92121
9171 TOWNE CENTRE DRIVE, SUITE 440, SAN DIEGO, CA 92122
4275 EXECUTIVE SQUARE, SUITE 200, LA JOLLA, CA 92037
80 WEST SIERRA MADRE BLVD., #392, SIERRA MADRE, CA 91024
Phone Numbers
(858) 964-5123
858-964-5123
626-227-1630
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
NEVADA
Total Amount Raised:
$14,652,914.00
Number of Funding Rounds:
16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2019-01-03
$3,171,445.00
$3,171,445.00
$0.00
Equity
15
2017-07-20
$145,200.00
$145,200.00
$0.00
Equity
14
2016-06-30
$3,000,000.00
$3,000,000.00
$0.00
Debt
13
2015-08-03
$500,000.00
$1,500,000.00
$1,000,000.00
Equity
12
2014-02-19
$742,300.00
$742,300.00
$0.00
Equity
11
2014-02-13
$330,000.00
$330,000.00
$0.00
Debt
10
2013-12-24
$0.00
INDEFINITE
INDEFINITE
Equity
9
2013-12-23
$350,000.00
$350,000.00
$0.00
Debt
8
2013-06-12
$134,640.00
$134,640.00
$0.00
Equity
7
2013-05-15
$50,000.00
$50,000.00
$0.00
Debt
6
2013-04-19
$450,000.00
$450,000.00
$0.00
Equity
5
2013-02-15
$4,484,661.00
$6,000,000.00
$1,515,339.00
Equity
4
2013-01-15
$1,070,000.00
$1,070,000.00
$0.00
Debt
3
2012-03-22
$0.00
$0.00
$0.00
Equity
2
2012-01-13
$174,668.00
$174,668.00
$0.00
Debt
1
2011-12-07
$50,000.00
$50,000.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
RANDY
BERHOLTZ
EXECUTIVE OFFICER
BASSAM
DAMAJ
EXECUTIVE OFFICER, DIRECTOR
HENRY
ESBER
DIRECTOR
VIVIAN
LIU
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$5,000,001 - $25,000,000
Equity
2019-01-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$5,000,001 - $25,000,000
Equity
2017-07-20
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Debt
2016-06-30
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-08-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-08-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-02-19
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-02-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Debt
2013-12-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2013-12-24
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-05-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2011-12-07
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2011-12-07
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-01-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2012-01-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-06-12
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-02-15
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

